Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4336 to 4350 of 7691 results

  1. Mid-life interventions:- In the UK, which mid-life groups are currently at most risk of losing their independence or experiencing poor mental wellbeing in later life? And which interventions are most effective and cost effective in preparing these people for later life?

    Recommendation ID NG32/6 Question Mid-life interventions:- In the UK, which mid-life groups are currently at most risk of losing their

  2. Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young people should be used only in research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG765/1 Question Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children

  3. Minimally invasive pancreatectomy:- Prospective randomised trials should be undertaken to compare the effectiveness of minimally invasive pancreatectomy or pancreatoduodenectomy (laparoscopic or robotic) with open pancreatectomy or pancreatoduodenectomy in people with pancreatic cancer.

    Recommendation ID NG85/3 Question Minimally invasive pancreatectomy:- Prospective randomised trials should be undertaken to compare the

  4. What are the effective forms of remobilisation for people with MSCC?

    Recommendation ID NG234/3 Question What are the effective forms of remobilisation for people with MSCC? Any explanatory notes(if

  5. Modes of provision of support to healthcare professionals:- What would be the impact of dietetic telephone support to healthcare professionals to aid in the diagnosis and assessment of babies showing non-IgE-mediated food allergy symptoms in primary care and community settings?

    Recommendation ID CG116/5 Question Modes of provision of support to healthcare professionals:- What would be the impact of dietetic telephone

  6. Monitoring adherence to treatment:- What is the clinical and cost effectiveness of using electronic alert systems designed to monitor and improve adherence with regular inhaled maintenance therapy in people with asthma?

    Recommendation ID NG80/3 Question Monitoring adherence to treatment:- What is the clinical and cost effectiveness of using electronic alert

  7. Monitoring for cystic-fibrosis-related diabetes:- What is the most effective strategy to detect diabetes in people with cystic fibrosis?

    Recommendation ID NG78/5 Question Monitoring for cystic-fibrosis-related diabetes:- What is the most effective strategy to detect diabetes

  8. Monitoring inhaler technique:- What is the current frequency and the current method being used to check the inhaler technique of people with asthma? What is the optimal frequency and the best method of checking inhaler technique to improve clinical outcomes for people with asthma?

    Recommendation ID NG80/4 Question Monitoring inhaler technique:- What is the current frequency and the current method being used to check

  9. MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy Interventional procedures guidance

    Recommendation ID IPG671/1 Question MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy Interventional procedures

  10. Monitoring pulmonary disease:- Is lung clearance index a useful and cost-effective tool for the routine assessment and monitoring of changes in pulmonary status in people with cystic fibrosis?

    Recommendation ID NG78/3 Question Monitoring pulmonary disease:- Is lung clearance index a useful and cost-effective tool for the routine

  11. Mucoactive agents:- What is the most clinically and cost-effective dose of rhDNase (dornase alfa; recombinant human deoxyribonuclease) for people with cystic fibrosis?

    Recommendation ID NG78/6 Question Mucoactive agents:- What is the most clinically and cost-effective dose of rhDNase (dornase alfa; recombinant

  12. What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    Recommendation ID CG173/1 Question What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy

  13. Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    Recommendation ID CG173/1 Question Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness